Defensive Stocks Are Getting Expensive

Watch stocks you care about

The single, easiest way to keep track of all the stocks that matter...

Your own personalized stock watchlist!

It's a 100% FREE Motley Fool service...

Click Here Now

Ever since the financial crisis three years ago, nervous investors have gravitated toward industries that tend to hold up well during market downturns. But the resulting flood of money into defensive stocks has pushed valuations in the sector upward to the point at which the stocks aren't nearly as attractive as they once were -- and may not perform the way risk-averse shareholders would expect.

Looking for the perfect armor
The Holy Grail of investing is a stock that will deliver high returns without the volatility and risk that investors have become all too familiar with in recent years. With economic cycles seemingly becoming longer and more extreme, with a long period of expansion followed by the worst recession in decades, nearly everyone would love a stock that could give them stable, comfortable returns without the anxiety that keeps many investors awake at night.

Consumer staples stocks have a lot of those attractive attributes. They tend to move less violently than the market, lagging behind high-growth stocks during big bull markets but holding up far better in the inevitable downturns that follow. From a business perspective, these companies do a better job of sustaining sales and income even during bad times for one simple reason: The products they make are ones that consumers want and need. Cutting back just isn't an option for many customers, which helps keep those companies healthy.

Safety at any price?
The problem, though, is that even safe stocks can get expensive enough that they start being riskier than you'd expect -- and can stop giving you the returns you want. For instance, since 2012 began, the overall stock market has performed quite well. But many consumer staples have lagged behind. Consider these examples:

  • Just yesterday, Kimberly-Clark (NYSE: KMB  ) said that the rising costs of raw materials would cause its 2012 earnings to fall below what analysts had expected. Already, the company has seen a big impact from those costs, with 2011 earnings falling 14% from previous-year levels. Yet even after a decline yesterday, the stock still fetches more than 17 times trailing earnings.
  • Dow component Procter & Gamble (NYSE: PG  ) has fallen about 2.5% since the beginning of 2012, severely underperforming the Dow Industrials overall. Although its pricing power gives it more protection from raw material inflation than Kimberly-Clark, P&G nevertheless still trades at a P/E of 16 even after its decline so far this year. Moreover, analysts expect a small decline in profits versus last year's levels when the company reports on Friday.
  • Colgate-Palmolive (NYSE: CL  ) weighs in with an earnings multiple of nearly 18, despite facing many of the same challenges as its peers. Clorox (NYSE: CLX  ) is even pricier, sporting a 20 P/E on long-term growth expectations that fall behind both Colgate and P&G.
  • Even must-have product sellers are seeing pressure. Cigarette maker Altria (NYSE: MO  ) is down almost 5% for the month so far and trades at a P/E of 17. It too announces earnings on Friday, but analysts are more optimistic, expecting modest growth from the tobacco giant.

One thing that all of these stocks share is that they pay good dividends. In this income-starved environment, high-yielding dividend stocks have gotten more popular than ever. That makes sense given the reputation that dividend payers have as ballast in a downturn.

I'm not saying these are bad stocks. But any hot investment can get bid up too far. If the economy fails to deliver on the promises investors expect from it, then these stocks could drop further than they have in previous downturns. And conversely, with such strong gains already incorporated into their stock prices, defensive plays may lag even worse than growth stocks in the next big bull market.

Be safe
None of this should stop you from managing your risk level to match what you're willing to live with. But keep in mind that no matter how safe a stock may have been in the past, there's still an upper limit on what you should be willing to pay for it. If you remember that, then you should avoid making the mistakes that led so many investors into trouble during the last bear market.

Are you trying to retire comfortably? Our latest special free report reveals the shocking can't-miss truth about your retirement -- and what you can do about it. Grab a copy today and find out everything you need to know.

Fool contributor Dan Caplinger waits for bargains. You can follow him on Twitter here. He doesn't own shares of the companies mentioned in this article. The Motley Fool owns shares of Clorox and Altria. Motley Fool newsletter services have recommended buying shares of Procter & Gamble and Kimberly-Clark. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Fool's disclosure policy won't cost you too much.

Read/Post Comments (1) | Recommend This Article (15)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On February 04, 2012, at 11:57 PM, Dizzy28 wrote:


    I agree and was just noting the same thing in another article. This entire space seems to be stuck. It's starting to become overvalued, with PEGs almost at 2 for most of these names. In a 2008 environment, I'd be looking to add, but right now, they all look the same, and seems to be alot more bargains in other sectors.

    Some of these names have much better debt loads than others, but from a growth standpoint, none of them stick out. The Fool staff tends to like Unilever because of the emerging markets growth, so if someone was needing a consumer staples name that might be the way to go, but for those of us that already have that slot filled, seems like time to keep it steady and just hold on and collect the cash.

    I don't think anyone will lose money on any of these names, but seems to be much more growth opportunity elsewhere right now.

Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1764954, ~/Articles/ArticleHandler.aspx, 10/24/2016 11:37:29 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 2 hours ago Sponsored by:
DOW 18,223.03 77.32 0.43%
S&P 500 2,151.33 10.17 0.47%
NASD 5,309.83 52.43 1.00%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/24/2016 4:00 PM
CL $71.03 Up +0.11 +0.16%
Colgate-Palmolive CAPS Rating: ****
CLX $118.66 Down -0.59 -0.49%
The Clorox Company CAPS Rating: ****
KMB $113.91 Down -5.67 -4.74%
Kimberly-Clark CAPS Rating: ****
MO $64.95 Up +1.25 +1.96%
Altria Group CAPS Rating: ****
PG $84.10 Down -0.23 -0.27%
Procter and Gamble CAPS Rating: ****